Allogeneic peripheral blood stem cell transplantation for metastatic renal cell carcinoma

Journal of Urology

Volumn 165, Issue 4, 2001, Pages 1208-1209

  Rini, Brian I ^a   Zimmerman, Todd M ^a   Gajewski, Thomas F ^a   Stadler, Walter M ^a   Vogelzang, Nicholas J ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Carcinoma; Hematopoietic stem cell transplantation; Kidney; Renal cell

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FLAVOPIRIDOL; FLUOROURACIL; GEMCITABINE; INTERLEUKIN 2; TACROLIMUS; TEMOZOLOMIDE;

ADULT; ALLOGRAFT; ARTICLE; CASE REPORT; GRAFT REJECTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; KIDNEY CARCINOMA; MALE; MEDIASTINUM MASS; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; THORAX PAIN;

EID: 0035093298     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)66479-8     Document Type: Article

References (4)

1. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts
2. In situ demonstration of renal-cell-carcinoma-specific T-cell clones
3. Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: Evidence for a graft-versus-tumor effect
4. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation